HOME >> BIOLOGY >> NEWS
2002 Cold Spring Harbor Laboratory Meetings

The new season of scientific meetings at Cold Spring Harbor Laboratory is about to commence.

Cold Spring Harbor Meetings provide excellent opportunities for reporting on and keeping current with a broad range of new discoveries in the biological and biomedical sciences, from cancer genetics, the cell cycle, brain development, and aging to tissue engineering, genomics, mouse molecular genetics, and retrovirus research.

The first meeting, New Horizons in Molecular Imaging: Genes, Probes, & Disease, will take place March 14 - 17, 2002. It is organized by researchers from Johns Hopkins University School of Medicine, the National Cancer Institute, Washington University in St. Louis, and Massachusetts General Hospital.

A complete list of 2002 Cold Spring Harbor Laboratory Meetings is available at the following website: http://nucleus.cshl.org/meetings/2002meetings.htm

For more information, or to register to attend a meeting, please visit https://nucleus.cshl.org/secmeetings/media.htm call 516-367-6947, or e-mail sherwood@cshl.org.


'"/>

Contact: Peter Sherwood
sherwood@cshl.org
516-367-6947
Cold Spring Harbor Laboratory
1-Feb-2002


Page: 1

Related biology news :

1. Spring through fall, cities are greener longer than neighboring rural regions
2. Springtime blooms seen earlier now than in the past, say Boston University biologists
3. Springer - A solution to water pollution?
4. LabNotes - Spring 2001
5. Spring meeting press conferences
6. 2000 Spring Meeting: Sessions and abstracts online
7. 2000 Spring Meeting press registration
8. Media Advisory: 1999 Spring Meeting -- Updated Press Conference Schedule
9. 1999 Spring Meeting: Information For Media Representatives
10. Biologist Wins Simon Fraser University Controversy Prize For Silent Spring Of The 90s
11. Press Events At Spring Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Cold Spring Harbor Laboratory Meetings

(Date:2/13/2015)... , Feb. 13, 2015 ACT ... company that aims to transform cancer genomic information ... that the company has raised US$ 8 million in ... Based in Taipei, Taiwan , ... ACTDrug™, ACTOnco™. With the aim to implement next ...
(Date:2/9/2015)... RICHARDSON, Texas , Feb. 9, 2015  Lintec ... novel fabrication methods for carbon nanotube (CNT) macrostructures, including ... Texas at Dallas (UTD). Leveraging the vast ... Tokyo, Japan , Lintec of America ... Richardson, TX , focusing on scaling ...
(Date:2/5/2015)... 2015   Marvin Test Solutions , ... test solutions for military, aerospace, and manufacturing ... TS-323 GENASYS Test Platform to ... is a high-performance PXI-based system designed to ... require performance functional testing. GENASYS features a ...
Breaking Biology News(10 mins):ACT Genomics Raises $8 Million in its First Private Funding Round 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 4
(Date:2/28/2015)... 2015 Increasing its efforts to resolve the ... first three episodes of The GMO TRUTH podcast on both ... as it continues its mission to discover the truth and ... phase, to “uncover the truth about the GMOs in our ... GMO Truth Podcast is an expansion of the documentary/investigative film-making ...
(Date:2/27/2015)... Calif. , Feb. 27, 2015  Pharmacyclics, ... that longer-term toxicology studies for its newly developed ... or RA, have been completed. The results of ... U.S. Food and Drug Administration. The feedback received ... of the ongoing first-in-human study. Additional preclinical work ...
(Date:2/27/2015)... Halifax, Nova Scotia (PRWEB) February 27, 2015 ... clinical stage vaccine and immunotherapy company, today announced ... approved its application for Fast Track designation and ... DPX-Ebola vaccines, in conjunction with the mutual co-development ... had previously obtained Fast Track designation for the ...
(Date:2/27/2015)... , Feb. 27, 2015  Pfenex Inc. (NYSE ... development of biosimilar therapeutics, today announced that it will ... Marriott Marquis on March 2 nd at 3pm ... on a panel discussing the current state of the ... Biosimilars . For more information on ...
Breaking Biology Technology:The Walk a Mile Project Launches “GMO Truth” Podcast 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 3Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3
Cached News: